July 19, 2024
Kidney Transplant Market

Growing Prevalence Of Organ Failure To Foster Expansion Of The Global Kidney Transplant Market

The global Kidney Transplant Market is estimated to be valued at US$ 5.8 billion in 2023 and is expected to exhibit a CAGR of 4.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

The kidney transplant market deals in transplantation of kidneys from healthy donors to patients suffering from kidney failure. Kidney transplantation is a major treatment option for end-stage renal disease. It involves surgically placing a healthy kidney from a living or deceased donor into the recipient’s body. Kidney transplantation provides better quality of life and longer lifespan as compared to dialysis. It eliminates the need for frequent dialysis and allows recipients to lead an active disease-free life.

Market key trends:

One of the key trends in the kidney transplant market is the rising adoption of deceased donor transplantation. Deceased donor transplantation involves transplanting kidneys retrieved from brain-dead or heart-beat dead donors. It accounts for majority of kidney transplants performed worldwide. The number of deceased donor transplantations is increasing owing to growing organ donor registry programs and improving organ matching and allocation systems. This is boosting the growth of the overall kidney transplant market.

Porter’s Analysis:

Threat of new entrants: The threat of new entrants in the kidney transplant market is moderate. High capital requirement for R&D and manufacturing facilities pose barriers for new companies.

Bargaining power of buyers: The bargaining power of buyers is low to moderate. However, the need for kidney transplants provides buyers with some bargaining power.

Bargaining power of suppliers: The bargaining power of suppliers is high due to the scarce availability of transplantable organs. Suppliers can influence prices of organs and related technologies.

Threat of new substitutes: The threat of new substitutes is low as no close substitute is available for kidney transplants currently. Research in organ engineering offers potential new substitutes in long-term.

Competitive rivalry: Competition in the kidney transplant market is high among existing players. Manufacturers compete based on service quality, product differentiation, and pricing.

Key Takeaways:

The Global Kidney Transplant Market Size is expected to witness high growth, exhibiting CAGR of 4.2% over the forecast period, due to increasing prevalence of kidney failure and shortage of donors.

On a regional level, North America dominated the kidney transplant market in 2023 and is expected to continue its dominance over the forecast period. This is attributed to higher healthcare spending, advanced medical facilities, and large patient pool in the US and Canada. However, Asia Pacific is anticipated to witness fastest growth rate owing to growing patient awareness, improving healthcare infrastructure, and increasing healthcare expenditures in major countries like China and India.

Key players operating in the kidney transplant market are Sanofi, Pfizer, Inc., Novartis AG., B. Braun Melsungen AG, Fresenius Medical Care, Medtronic, Preservation Solution Inc., TransMedics, Inc., Organ Recovery Systems, and Transonic Systems Inc. These players are focusing on new product launches, collaborations, and expansion strategies to gain higher market share.

*Note:
1.  Source: Coherent Market Insights, Public sources, Desk research
2.  We have leveraged AI tools to mine information and compile it